Nutritional management of (some) autism: A case for gluten- and casein-free diets?

Proceedings of the Nutrition Society

Volumn 74, Issue 3, 2015, Pages 202-207

  Whiteley, Paul ^a  

^a ESPA Research   (United Kingdom)

Author keywords

Autism spectrum disorder; Casein; Diet; Gluten; Intervention

Indexed keywords

AUTISM; BRAIN; CASEIN FREE DIET; CLINICAL EFFECTIVENESS; CONFERENCE PAPER; DIET THERAPY; DIGESTIVE SYSTEM; GLUTEN FREE DIET; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INTESTINE; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; METABOLISM; GENETICS; PROCEDURES;

CASEIN;

AUTISTIC DISORDER; CASEINS; DIET THERAPY; DIET, GLUTEN-FREE; HUMANS;

EID: 84937635545     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665114001475     Document Type: Conference Paper

References (59)

1. Kanner L (1943) Autistic disturbances of affective contact. Nervous Child 2, 217-250.
2. Murdoch JD & State MW (2013) Recent developments in the genetics of autism spectrum disorders. Curr Opin Genet Dev 23, 310-315.
3. Rangasamy S, D'Mello SR & Narayanan V (2013) Epigenetics, autism spectrum, and neurodevelopmental disorders. Neurotherapeutics 10, 742-756.
4. Volk HE, Kerin T, Lurmann F et al. (2014) Autism spectrum disorder: interaction of air pollution with the MET receptor tyrosine kinase gene. Epidemiology 25, 44-47.
5. Zerbo O, Qian Y, Yoshida C et al. (2013) Maternal infection during pregnancy and autism spectrum disorders. J Autism Dev Disord (In the Press).
6. Whitehouse AJ & Stanley FJ (2013) Is autism one or multiple disorders? Med J Aust 198, 302-303.
7. Fountain C, Winter AS & Bearman PS (2012) Six developmental trajectories characterize children with autism. Pediatrics 129, e1112-e1120.
8. Fein D, Barton M, Eigsti IM et al. (2013) Optimal outcome in individuals with a history of autism. J Child Psychol Psychiatry 54, 195-205.
9. Mukaddes NM, Tutkunkardas MD, Sari O et al. (2014) Characteristics of children who lost the diagnosis of autism: a sample from Istanbul, Turkey. Autism Res Treat 2014, 472120.
10. Developmental Disabilities Monitoring Network Surveillance Year 2010 Principal Investigators (2014) Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill Summ 63, 1-21.
11. Viscidi EW, Triche EW, Pescosolido MF et al. (2013) Clinical characteristics of children with autism spectrum disorder and co-occurring epilepsy. PLoS ONE 8, e67797.
12. Gillberg C & Fernell E (2014) Autism plus versus autism pure. J Autism Dev Disord (In the Press).
13. Novarino G, El-Fishawy P, Kayserili H et al. (2012) Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy. Science 338, 394-397.
14. Kotagal S & Broomall E (2012) Sleep in children with autism spectrum disorder. Pediatr Neurol 47, 242-251.
15. McElhanon BO, McCracken C, Karpen S et al. (2014) Gastrointestinal symptoms in autism spectrum disorder: a meta-analysis. Pediatrics (In the Press).
16. Walker SJ, Fortunato J, Gonzalez LG et al. (2013) Identification of unique gene expression profile in children with regressive autism spectrum disorder (ASD) and ileocolitis. PLoS ONE 8, e58058.
17. Chandler S, Carcani-Rathwell I, Charman T et al. (2013) Parent-reported gastro-intestinal symptoms in children with autism spectrum disorders. J Autism Dev Disord 43, 2737-2747.
18. Reichelt KL & Knivsberg AM (2009) The possibility and probability of a gut-to-brain connection in autism. Ann Clin Psychiatry 21, 205-211.
19. Millward C, Ferriter M, Calver S et al. (2008) Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database Syst Rev CD003498.
20. Buie T (2013) The relationship of autism and gluten. Clin Ther 35, 578-583.
21. Marí-Bauset S, Zazpe I, Mari-Sanchis A et al. (2014) Evidence of the gluten-free and casein-free diet in autism spectrum disorders: a systematic review. J Child Neurol (In the Press).
22. Whiteley P, Shattock P, Knivsberg AM et al. (2013) Gluten- and casein-free dietary intervention for autism spectrum conditions. Front Hum Neurosci 6, 344.
23. Heilskov Rytter MJ, Andersen LB, Houmann T et al. (2014) Diet in the treatment of ADHD in children-A systematic review of the literature. Nord J Psychiatry 16, 1-18.
24. Pedersen L, Parlar S, Kvist K et al. (2014) Data mining the ScanBrit study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders: behavioural and psychometric measures of dietary response. Nutr Neurosci 17, 207-213.
25. Whiteley P, Haracopos D, Knivsberg AM et al. (2010) The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders. Nutr Neurosci 13, 87-100.
26. Anderson RJ, Bendell DJ, Garnett I et al. (2002) Identification of indolyl-3-acryloylglycine in the urine of people with autism. J Pharm Pharmacol 54, 295-298.
27. Goodwin MS, Cowen MA & Goodwin TC (1971) Malabsorption and cerebral dysfunction: a multivariate and comparative study of autistic children. J Autism Child Schizophr 1, 48-62.
28. Dohan FC (1988) Genetic hypothesis of idiopathic schizophrenia: its exorphin connection. Schizophr Bull 14, 489-494.
29. Asperger H (1961) Psychopathology of children with coeliac disease. Ann Paediatr 197, 346-351.
30. Genuis SJ, Bouchard TP (2010) Celiac disease presenting as autism. J Child Neurol 25, 114-119.
31. Batista IC, Gandolfi L, Nobrega YK et al. (2012) Autism spectrum disorder and celiac disease: no evidence for a link. Arq Neuropsiquiatr 70, 28-33.
32. Zioudrou C, Streaty RA & Klee WA (1979) Opioid peptides derived from food proteins. The exorphins. J Biol Chem 254, 2446-2449.
33. Fukudome S, Jinsmaa Y, Matsukawa T et al. (1997) Release of opioid peptides, gluten exorphins by the action of pancreatic elastase. FEBS Lett 412, 475-479.
34. Sahley TL & Panksepp J (1987) Brain opioids and autism: an updated analysis of possible linkages. J Autism Dev Disord 17, 201-216.
35. Gillberg C (1995) Endogenous opioids and opiate antagonists in autism: brief review of empirical findings and implications for clinicians. Dev Med Child Neurol 37, 239-245.
36. Knivsberg AM, Reichelt KL & Nødland M (2001) Reports on dietary intervention in autistic disorders. Nutr Neurosci 4, 25-37.
37. Roy A, Roy M, Deb S et al. (2014) Are opioid antagonists effective in attenuating the core symptoms of autism spectrum conditions in children: a systematic review. J Intellect Disabil Res (In the Press).
38. Reichelt KL, Hole K, Hamberger A et al. (1981) Biologically active peptide-containing fractions in schizophrenia and childhood autism. Adv Biochem Psychopharmacol 28, 627-643.
39. Hunter LC, O'Hare A, Herron WJ et al. (2003) Opioid peptides and dipeptidyl peptidase in autism. Dev Med Child Neurol 45, 121-128.
40. Williams BL, Hornig M, Buie T et al. (2011) Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS ONE 6, e24585.
41. Kushak RI, Lauwers GY, Winter HS et al. (2011) Intestinal disaccharidase activity in patients with autism: effect of age, gender, and intestinal inflammation. Autism 15, 285-294.
42. D'Eufemia P, Celli M, Finocchiaro R et al. (1996) Abnormal intestinal permeability in children with autism. Acta Paediatr 85, 1076-1079.
43. Shattock P & Whiteley P (2002) Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opin Ther Targets 6, 175-183.
44. de Magistris L, Familiari V, Pascotto A et al. (2010) Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr 51, 418-424.
45. de Magistris L, Picardi A, Siniscalco D et al. (2013) Antibodies against food antigens in patients with autistic spectrum disorders. Biomed Res Int 2013, 729349.
46. Dalton N, Chandler S, Turner C et al. (2014) Gut permeability in autism spectrum disorders. Autism Res 7, 305-313.
47. Masi A, Quintana DS, Glozier N et al. (2014) Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis. Mol Psychiatry (In the Press).
48. Jyonouchi H, Geng L, Cushing-Ruby A et al. (2008) Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J Neuroinflammation 5, 52.
49. Mostafa GA, El-Sherif DF & Al-Ayadhi LY (2014) Systemic auto-antibodies in children with autism. J Neuroimmunol 272, 94-98.
50. Brown AC & Mehl-Madrona L (2011) Autoimmune and gastrointestinal dysfunctions: does a subset of children with autism reveal a broader connection? Expert Rev Gastroenterol Hepatol 5, 465-477.
51. Ashwood P, Anthony A, Torrente F et al. (2004) Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10. J Clin Immunol 24, 664-673.
52. Jyonouchi H, Sun S & Itokazu N (2002) Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology 46, 76-84.
53. Lau NM, Green PH, Taylor AK et al. (2013) Markers of celiac disease and gluten sensitivity in children with Autism. PLoS ONE 8, e66155.
54. Ludvigsson JF, Reichenberg A, Hultman CM et al. (2013) A nationwide study of the association between celiac disease and the risk of autistic spectrum disorders. JAMA Psychiatry 70, 1224-1230.
55. Severance EG, Alaedini A, Yang S et al. (2012) Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophr Res 138, 48-53.
56. Panda S, Guarner F & Manichanh C (2014) Structure and functions of the gut microbiome. Endocr Metab Immune Disord Drug Targets (In the Press).
57. Borre YE, Moloney RD & Clarke G (2014) The impact of microbiota on brain and behavior: mechanisms and therapeutic potential. Adv Exp Med Biol 817, 373-403.
58. Cao X, Lin P, Jiang P et al. (2013) Characteristics of the gastrointestinal microbiome in children with autism spectrum disorder: a systematic review. Shanghai Arch Psychiatry 25, 342-353.
59. Hsiao EY, McBride SW, Hsien S et al. (2013) Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155, 1451-1463.